文献速递腹部技术与安全US

脾囊性病变的超声诊断方法:111例患者的回顾性研究

Cystic splenic lesions: a sonographic approach-retrospective study in 111 patients.
PubMed 文献 · Eur Radiol · 2024-09-09

回顾性分析111例脾囊性病变患者的B型超声、彩色多普勒及超声造影表现,将病变分为0-III四型,并定义「有风险的脾囊性病变」。恶性病变仅见于II型(8.2%)和III型(20.9%),「有风险的脾囊性病变」在0型(100%)、II型(66.7%)和III型(30.2%)中比I型(3%)更常见,差异有统计学意义(p<0.001)。

要点

  • 脾囊性病变分为0-III型,恶性病变仅见于II型和III型
  • 「有风险的脾囊性病变」需进一步处理,在0型、II型、III型中更常见
  • B型超声联合彩色多普勒和超声造影有助于脾囊性病变的定性及随访

核心结论

  • B型超声、彩色多普勒和超声造影有助于进一步定性、随访脾囊性病变,并识别需要进一步处理的「有风险的脾囊性病变」。

研究设计与样本

  • 2003年至2023年间在一个跨学科超声中心开展的回顾性研究,纳入111例脾囊性病变患者,采用B型超声、彩色多普勒和超声造影检查,以组织学检查或影像随访确定病变性质。

关键影像表现/征象

  • 脾囊性病变根据回声、直径、形态以及分隔、钙化、壁增厚等特征进行描述和分型。
  • 彩色多普勒和超声造影用于识别病变的血流灌注情况。

诊断标准与关键数值

  • 最终诊断:脾囊肿64例(57.7%)、脾脓肿10例(9.0%)、脾内假性动脉瘤10例(9.0%)、脾转移瘤10例(9.0%)、脾梗死6例(5.4%)、脾血肿4例(3.6%)、其他7例(6.3%)。
  • 脾囊性病变分型:0型11例(9.9%)、I型33例(29.7%)、II型24例(21.6%)、III型43例(38.7%)。
  • 「有风险的脾囊性病变」诊断41例(36.9%)。
  • 恶性脾囊性病变仅见于II型(2例,8.2%)和III型(9例,20.9%)(p<0.001)。
  • 「有风险的脾囊性病变」在0型(11例,100%)、II型(16例,66.7%)和III型(13例,30.2%)中比I型(1例,3%)更常见(p<0.001)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To describe and categorize splenic cystic-appearing lesions (S-CAL) with B-mode and contrast-enhanced ultrasound (CEUS).

MATERIALS AND METHODS: This retrospective study investigated S-CALs in 111 patients between 2003 and 2023 in an interdisciplinary ultrasound center with B-mode ultrasound, color Doppler sonography (CDS), and CEUS. S-CAL was characterized by echogenicity, diameter, and shape, as well as additional features like septation, calcification, or wall thickening, and CDS/CEUS were used to identify perfusion. Histological examination or imaging follow-up was necessary to determine the nature of S-CAL. Moreover, 'S-CAL with risk' was defined, necessitating further procedures. Four types (0-III) of S-CALs were defined based on ultrasound parameters. Fisher's exact test was used to compare non-parametric data.

RESULTS: S-CAL of 111 patients (58 female, 53 men-average age: 58.6 years) was examined. Final diagnoses were: splenic cyst (n = 64, 57.7%); splenic abscess (n = 10, 9.0%); intrasplenic pseudoaneurysm (n = 10, 9.0%); splenic metastasis (n = 10, 9.0%); splenic infarction (n = 6, 5.4%); splenic hematoma (n = 4, 3.6%); other (n = 7, 6.3%). S-CAL groupings were type 0 (n = 11, 9.9%), type I (n = 33, 29.7%), type II (n = 24, 21.6%), and type III (n = 43, 38.7%). 'S-CAL with risk' was diagnosed in n = 41 (36.9%). Malignant S-CAL was only seen in type II (n = 2, 8.2%) and type III (n = 9, 20.9%) (p < 0.001). 'S-CALs with risk' were found more frequently in type 0 (n = 11, 100%), type II (n = 16, 66.7%) and type III (n = 13, 30.2%) than in type I (n = 1, 3%) (p < 0.001).

CONCLUSION: B-mode ultrasound, CDS, and CEUS are useful to further characterize and follow-up S-CAL and identify 'S-CAL with risk', requiring further procedures.

CLINICAL RELEVANCE STATEMENT: Ultrasound imaging is valuable for the detection, categorization, and monitoring of cystic-appearing lesions of the spleen, as well as for the identification of those with risk.

KEY POINTS: An S-CAL may introduce uncertainty in clinical practice as imaging-based risk stratification is missing. B-mode and CEUS, along with the clinical context and follow-up, assist in characterizing and identifying 'S-CAL with risk'. S-CALs encompass various lesions, including simple cysts, metastases, abscesses, and intrasplenic pseudoaneurysms.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Findeisen H, Zayed T, Görg C, et al. Cystic splenic lesions: a sonographic approach-retrospective study in 111 patients. Eur Radiol. 2024. PMID: 39251443. doi:10.1007/s00330-024-11050-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。